Orbimed Advisors LLC

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 107
Total Value: 4035711615
Accession Number: 0001172661-25-002355
Form Type: 13F-HR
CIK: 0001055951
Manager Name: Orbimed Advisors LLC

Data Enrichment

92% identified

98 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

107 positions • $4,035,711.615K total value

107 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 2 of 6

Sort by:

CYTOKINETICS INC

CYTK|23282W605

1509205(-4.7%)

Value:

$60.7B(-18.6%)

CG Oncology, Inc.

CGON|156944100

2471994(+72.7%)

Value:

$60.5B(+47.5%)

ArriVent BioPharma, Inc.

AVBP|04272N102

3027328(+0.0%)

Value:

$56.0B(-30.6%)

Avidity Biosciences, Inc.

RNA|05370A108

1812886(+62.9%)

Value:

$53.5B(+65.4%)

SI-BONE, Inc.

SIBN|825704109

3442853(+0.0%)

Value:

$48.3B(+0.1%)

Axsome Therapeutics, Inc.

AXSM|05464T104

386700

Value:

$45.1B

Compass Therapeutics, Inc.

CMPX|20454B104

22362850(+0.0%)

Value:

$42.5B(+31.0%)

NeuroPace Inc

NPCE|641288105

3406335(+0.0%)

Value:

$41.9B(+9.8%)

829401108

3704959

Value:

$38.8B

Upstream Bio, Inc.

UPB|91678A107

5693589(+0.0%)

Value:

$34.8B(-62.8%)

Xtant Medical Holdings, Inc.

XTNT|98420P308

73114592(+0.0%)

Value:

$34.4B(+6.1%)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

653743

Value:

$33.6B

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

999000(+0.0%)

Value:

$33.5B(-34.4%)

Xenon Pharmaceuticals Inc.

XENE|98420N105

947877(+0.0%)

Value:

$31.8B(-14.4%)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

1432300

Value:

$31.3B

MBX Biosciences, Inc.

MBX|55287L101

4002887(+5.0%)

Value:

$29.5B(-58.0%)

EXACT SCIENCES CORP

EXAS|30063P105

679816(+0.0%)

Value:

$29.4B(-22.9%)

GILEAD SCIENCES, INC.

GILD|375558103

197500(-19.6%)

Value:

$22.1B(-2.5%)

Corvus Pharmaceuticals, Inc.

CRVS|221015100

6943654(+0.0%)

Value:

$22.1B(-40.6%)

Terns Pharmaceuticals, Inc.

TERN|880881107

7562971(+0.0%)

Value:

$20.9B(-50.2%)

Instrument	Shares		Other Manager	Value
Cytokinetics Inc(CYTKcusip23282W605)	1.5M	QoQ -4.72% (-74.8K) YoY +121.06% (+826.5K)	All Managers (Combined)	$60.7M	QoQ -18.59% (-$13.9M) YoY +26.72% (+$12.8M)
Cg Oncology, Inc.(CGONcusip156944100)	2.5M	QoQ +72.73% (+1.0M) YoY NEW(+2.5M)	All Managers (Combined)	$60.5M	QoQ +47.49% (+$19.5M) YoY NEW(+$60.5M)
Arrivent Biopharma, Inc.(AVBPcusip04272N102)	3.0M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$56.0M	QoQ -30.59% (-$24.7M) YoY +3.52% (+$1.9M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	1.8M	QoQ +62.89% (+700.0K) YoY +82.36% (+818.8K)	All Managers (Combined)	$53.5M	QoQ +65.36% (+$21.2M) YoY +110.94% (+$28.1M)
Si-Bone, Inc.(SIBNcusip825704109)	3.4M	QoQ 0.00% (+0) YoY +8.45% (-268.3K)	All Managers (Combined)	$48.3M	QoQ +0.07% (+$34.4K) YoY -7.05% (-$3.7M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	386.7K	QoQ NEW(+386.7K) YoY NEW(+386.7K)	All Managers (Combined)	$45.1M	QoQ NEW(+$45.1M) YoY NEW(+$45.1M)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	22.4M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$42.5M	QoQ +31.03% (+$10.1M) YoY -4.04% (-$1.8M)
Neuropace Inc(NPCEcusip641288105)	3.4M	QoQ 0.00% (+0) YoY -14.92% (-597.6K)	All Managers (Combined)	$41.9M	QoQ +9.83% (+$3.7M) YoY -20.79% (-$11.0M)
(cusip829401108)✕	3.7M	QoQ NEW(+3.7M) YoY NEW(+3.7M)	All Managers (Combined)	$38.8M	QoQ NEW(+$38.8M) YoY NEW(+$38.8M)
Upstream Bio, Inc.(UPBcusip91678A107)	5.7M	QoQ 0.00% (-0) YoY NEW(+5.7M)	All Managers (Combined)	$34.8M	QoQ -62.77% (-$58.8M) YoY NEW(+$34.8M)
Xtant Medical Holdings, Inc.(XTNTcusip98420P308)	73.1M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$34.4M	QoQ +6.09% (+$2.0M) YoY -59.82% (-$51.2M)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	653.7K	QoQ NEW(+653.7K) YoY NEW(+653.7K)	All Managers (Combined)	$33.6M	QoQ NEW(+$33.6M) YoY NEW(+$33.6M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	999.0K	QoQ 0.00% (-0) YoY -27.87% (-386.0K)	All Managers (Combined)	$33.5M	QoQ -34.40% (-$17.6M) YoY -48.31% (-$31.3M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	947.9K	QoQ 0.00% (-0) YoY +72.34% (+397.9K)	All Managers (Combined)	$31.8M	QoQ -14.41% (-$5.4M) YoY +34.31% (+$8.1M)
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	1.4M	QoQ NEW(+1.4M) YoY +854.86% (+1.3M)	All Managers (Combined)	$31.3M	QoQ NEW(+$31.3M) YoY +255.27% (+$22.5M)
Mbx Biosciences, Inc.(MBXcusip55287L101)	4.0M	QoQ +5.00% (-190.7K) YoY NEW(+4.0M)	All Managers (Combined)	$29.5M	QoQ -57.95% (-$40.7M) YoY NEW(+$29.5M)
Exact Sciences Corp(EXAScusip30063P105)	679.8K	QoQ 0.00% (-0) YoY +384.19% (+539.4K)	All Managers (Combined)	$29.4M	QoQ -22.95% (-$8.8M) YoY +203.51% (+$19.7M)
Gilead Sciences, Inc.(GILDcusip375558103)	197.5K	QoQ -19.58% (-48.1K) YoY NEW(+197.5K)	All Managers (Combined)	$22.1M	QoQ -2.45% (-$556.2K) YoY NEW(+$22.1M)
Corvus Pharmaceuticals, Inc.(CRVScusip221015100)	6.9M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$22.1M	QoQ -40.56% (-$15.1M) YoY +78.65% (+$9.7M)
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	7.6M	QoQ 0.00% (-0) YoY -0.73% (-56.2K)	All Managers (Combined)	$20.9M	QoQ -50.18% (-$21.0M) YoY -58.23% (-$29.1M)